Related Experiment Video
Updated: Jun 19, 2026
19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Update on antiretroviral therapy in paediatrics
Martina Penazzato1, Daniele Donà, Pia-Sophie Wool
1Department of Paediatrics, University of Padua, Via Giustiniani 3, 35128 Padova, Italy.
Antiviral Research
|November 3, 2009
Summary
Pediatric HIV management has advanced, but new infections persist, especially in developing nations. Optimizing treatment, preventing opportunistic infections, and addressing psychosocial needs are crucial for children living with HIV.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Significant progress in diagnosing and treating pediatric HIV infection has been achieved.
- Despite advances, new pediatric HIV infections remain a global concern, with over 1150 daily cases, predominantly in developing countries.
- Mother-to-child transmission (MTCT) is the primary route of infection in children.
Purpose of the Study:
- To review current management strategies for HIV infection in infants and children.
- To highlight ongoing challenges and necessary efforts in optimizing treatment and care for pediatric HIV.
- To emphasize the importance of preventing opportunistic infections and addressing long-term psychosocial consequences.
Main Methods:
- This is a review article, synthesizing current knowledge and research on pediatric HIV management.
- It draws upon data and recommendations from global health organizations (e.g., WHO).
- The review focuses on antiretroviral therapy, opportunistic infection prevention, and psychosocial support.
Main Results:
- Comprehensive strategies have reduced MTCT in Western countries, but further reductions are needed globally.
- Prompt initiation of potent and tolerable first-line antiretroviral therapy is central to effective management.
- Opportunistic infections, adherence, and psychosocial factors are increasingly critical considerations.
Conclusions:
- Continued efforts are required to further reduce MTCT and optimize care for HIV-infected children.
- Personalized interventions and new strategies are necessary to improve outcomes.
- Effective management necessitates a holistic approach, including timely treatment, infection prevention, and psychosocial support.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
02:33Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...